Quinazolin-2, 4-dione-based hydroxamic acids as selective histone deacetylase-6 inhibitors for treatment of non-small cell lung cancer CW Yu, PY Hung, HT Yang, YH Ho, HY Lai, YS Cheng, JW Chern Journal of medicinal chemistry 62 (2), 857-874, 2018 | 44 | 2018 |
A highly HDAC6-selective inhibitor acts as a fluorescent probe YH Ho, KJ Wang, PY Hung, YS Cheng, JR Liu, ST Fung, PH Liang, ... Organic & Biomolecular Chemistry 16 (42), 7820-7832, 2018 | 27 | 2018 |
Novel bisubstrate inhibitors for protein N-terminal acetyltransferase D Y Deng, S Deng, YH Ho, SM Gardner, Z Huang, R Marmorstein, R Huang Journal of medicinal chemistry 64 (12), 8263-8271, 2021 | 11 | 2021 |
Development of A Continuous Fluorescence-Based Assay for N-Terminal Acetyltransferase D YH Ho, L Chen, R Huang International Journal of Molecular Sciences 22 (2), 594, 2021 | 9 | 2021 |
Discovery of HDAC6, HDAC8, and 6/8 inhibitors and development of cell-based drug screening models for the treatment of TGF-β-induced idiopathic pulmonary fibrosis WC Yu, TY Yeh, CH Ye, PCT Chong, YH Ho, DK So, KY Yap, GR Peng, ... Journal of Medicinal Chemistry 66 (15), 10528-10557, 2023 | 7 | 2023 |
Effects of Oncohistone Mutations and PTM Crosstalk on the N-Terminal Acetylation Activities of NatD YH Ho, R Huang ACS Chemical Biology 18 (4), 693-700, 2022 | 7 | 2022 |
Histone deacetylases (HDACs) inhibitors JW Chern, CW Yu, JR Liu, YH Ho, CY Wu, C Huang, PY Hung US Patent 11,535,598, 2022 | 1 | 2022 |
Quinazoline derivatives useful as selective hdac6 inhibitors CW Yu, PY Hung, AD Jagtap, YH Ho, HY Chaing US Patent App. 18/001,002, 2023 | | 2023 |
Development of protein N-terminal acetyltransferase D inhibitors YH Ho, Y Deng, R Huang ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 263, 2022 | | 2022 |
Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for treatment of acute myeloid leukemia KD Wu, JR Liu, ST Fung, YH Ho, KJ Wang, GY Chen, AD Jagtap, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | | 2015 |
Design and synthesis of HDAC6 selective inhibitor as potential agent against glioblastoma YH Ho National Taiwan University, 2015 | | 2015 |